-
Founded in:
1999-02-03 -
Country:
China -
Address:
No. 8 Guangyuan East Street, Tongzhou Industrial Development Zone, Tongzhou District, Beijing -
Tax NO.:
91110112700216160K -
Registered Funds:
480 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ketoleucine calcium salt dihydrate |
Extract from the above information
More
Extract from the above information |
51828-95-6 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium 3-methyl-2-oxovalerate |
Unspecified
More
Unspecified |
66872-75-1 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium alpha-ketovaline |
Extract from the above information
More
Extract from the above information |
51828-94-5 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trimetazidine dihydrochloride |
Anti-angina drug. It has the effect of antagonizing adrenaline, norepinephrine and vasopressin, can reduce vascular resistance, increase coronary and circulatory blood flow, promote myocardial metabolism and myocardial energy production. At the same time, it can reduce myocardial oxygen consumption, thereby improving the balance of myocardial oxygen supply and demand. It can also increase tolerance to cardiac glycosides. By preserving the energy metabolism in ischemic cells and preventing the decrease of intracellular ATP levels, it ensures the perfect function of ion pumps and normal transmembrane sodium-potassium pump transport while maintaining the stability of the intracellular environment, reduces intracellular acidosis and prevents the accumulation of sodium and calcium in myocardial cells, protects cell contraction function and limits cell lysis and endothelial damage caused by oxygen free radicals.
More
Anti-angina drug. It has the effect of antagonizing adrenaline, norepinephrine and vasopressin, can reduce vascular resistance, increase coronary and circulatory blood flow, promote myocardial metabolism and myocardial energy production. At the same time, it can reduce myocardial oxygen consumption, thereby improving the balance of myocardial oxygen supply and demand. It can also increase tolerance to cardiac glycosides. By preserving the energy metabolism in ischemic cells and preventing the decrease of intracellular ATP levels, it ensures the perfect function of ion pumps and normal transmembrane sodium-potassium pump transport while maintaining the stability of the intracellular environment, reduces intracellular acidosis and prevents the accumulation of sodium and calcium in myocardial cells, protects cell contraction function and limits cell lysis and endothelial damage caused by oxygen free radicals. |
13171-25-0 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fexofenadine hydrochloride |
Unspecified
More
Unspecified |
153439-40-8 | 49 |